By Nicholas Bakalar
|Credit: Tim Boyle/Getty Images|
The observational study, published online recently in the Annals of Surgery, compared 1,923 cardiac patients who took aspirin before their operations and 945 who did not.
There were no significant differences between the two groups in body mass index, smoking status or congestive heart failure rates, but the patients taking aspirin were more likely to have a history of hypertension, diabetes, heart attack and other ailments.
Even though their health was generally poorer, the surgical patients who took aspirin before their operations fared better.
They had a lower risk of renal failure, a shorter stay in the intensive care unit, a reduced risk of major cardiac problems and a significant decrease in the risk for death in the month after the procedure. The authors believe that the anti-inflammatory properties of aspirin are responsible.
“The trend in cardiac surgery,” said the lead author, Dr. Jianzhong Sun, an anesthesiologist at Jefferson Medical College in Philadelphia, “is to continue the medication that patients need for their daily lives — aspirin and other medicines, as well.”
© 2011 The New York Times Company
Credit: Reports and photographs are property of owners of intellectual rights.
Seniors World Chronicle, a not-for-profit, serves to chronicle and widen their reach.